Lessons learned from first genetically-modifi

A new study published today in The Lancet has revealed the most extensive analysis to date on what led to the eventual heart failure in the world's first successful transplant of a genetically-modified pig heart into a human patient. This groundbreaking procedure was conducted by University of Maryland School of Medicine (UMSOM) physician-scientists back in January 2022 and marked an important milestone for medical science.

Related Keywords

,Markt Gladwin ,Akikok Bowers ,Bartley Griffith ,Alison Grazioli ,Avneeshk Singh ,Tianshu Zhang ,Muhammadm Mohiuddin ,Alice Marie Hales ,Christine Lau ,Kapil Saharia ,United Therapeutics Corporation ,University Of Maryland ,Members Of Program ,Drug Administration ,University Of Maryland School Medicine ,Revivicor Inc ,Xenotransplantation Program ,Method Of Research ,University Of Maryland Medical Center ,Kiniksa Pharmaceuticals ,Scientific Program ,Maryland School ,David Bennett ,Maryland Medical ,Program Director ,Cardiac Xenotransplantation Program ,Alice Marie Hales Distinguished Professor ,Vice President ,Medical Affairs ,Cardiac Xenotransplantation ,United Therapeutics ,Maryland Medical Center ,